Christopher Horan

Chief Tech Operations Officer · 2 filings · Latest: May 19, 2026

Artiva Biotherapeutics, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
ARTV	Christopher Horan	Chief Tech Operations Officer	May 19, 2026	Sale	$9.01	7,002	$63.1K	293,450	May 20 1:52 AM
ARTV	Christopher P. Horan	—	May 18, 2026	Proposed Sale	$9.22	7,500	$69.2K	—	May 18 11:53 PM